<DOC>
	<DOCNO>NCT02092246</DOCNO>
	<brief_summary>To determine accuracy unguided versus ultrasound ( US ) guide knee joint injection obese patient clinically detectable effusion .</brief_summary>
	<brief_title>Ultrasound Guided v Unguided Intra-articular Knee Injections</brief_title>
	<detailed_description>Patients BMI &gt; 30 clinically detectable knee effusion , clinical symptom radiographic evidence knee osteoarthritis inflammatory arthritis , refer intraarticular knee injection corticosteroid randomize either receive ultrasound guidance receive ultrasound guidance injection . One group use ultrasound guidance position needle . The group use landmarks position needle . For group , proceduralist comfortable needle placement injection , contrast dye inject fluoroscopy use , determine needle placement correct . If determine needle placement correct , fluoroscopy use reposition . Once needle placement determine acceptable , injection give . Patient demographic collect , along pain score preprocedure two week post-procedure . Subjects responsible clinical cost associate injection . There remuneration offer study participation .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis</mesh_term>
	<criteria>Inclusion Criteria BMI &gt; 30 No clinically detectable knee effusion Clinical radiographic evidence knee osteoarthritis inflammatory arthritis Must refer Pain Clinic treatment Exclusion Criteria History surgery affect knee Evidence untreated systemic infection systemic immunocompromise Evidence cutaneous infection near study knee injection site Patients warfarin INR &gt; 3.0 Patients oral antiplatelet anticoagulant medication exclude documented evidence renal insufficiency ( GFR &lt; 60 ) History iodinate contrast allergy significant reaction corticosteroid lidocaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>